一、项目单位：吕梁盛达生化有限公司。

　　二、项目概况：

　　       1、建设规模及内容：年产20吨硫酸软骨素、10吨溶菌酶。

　　       2、市场分析：用于生产生化原料药的生物原料极为丰富，但大部分在今后相当长的时期内还属于资源依赖性产品，虽然有的品种可以用基因重组等现代生物技术生产，但尚未达到商业化水平。而我们利用生物资源生产的生化药物，有效地保障了医药的临床需要，而且成为市场上的抢手货。硫酸软骨素已成为出口量最大的生化医药产品，主要销往美、欧等国。溶菌酶由于具有专一性分解细胞壁的能力，用途十分广泛，目前国内生产的该产品只能满足市场需求的三分之一，产品主销大连、上海。

　　       3、建设条件：该项目属国家鼓励投资项目，已批准进入离石轻工科技园区，建设条件及公用设施配套良好。硫酸软骨素是从猪、牛、羊等动物的软骨组织中，经碱提取蛋白质后制成的一种酸性粘多糖类药物。溶菌酶是从鸡蛋清中提取的一种酶制剂。上述产品的原料可就近解决。

　　       4、投资估算及资金筹措：总投资5000万元，其中自筹1000万元，拟引进资金4000万元。

　　       5、项目建设期：一年。

　　       6、效益分析：

　　       年可实现销售收入4160万元，实现利润1340万元，上交税金400万元。项目建成后，可新增就业人数200余人，同时可带动周边养殖业的快速发展。

　　       7、合作方式：合资、合作均可。

　　三、联系方式：

　　    联系地址：离石区发展计划局

　　       联 系 人：郭春元

　　       联系电话：0358-8222524

　　

　　

　　

　　Sulphuric Acid CartilageElement &&. Bacteriolytic Enzyme Production

　　Ｉ．Ｐｒｏｊｅｃｔ Ｕｎｉｔ

　　       Luliang  Shengda Biochemistry Co., Ltd

　　ＩＩ．Ｂｒｉｅｆ Ｉｎｔｒｏｄｕｃｔｉｏｎ ｔｏ ｔｈｅ Ｐｒｏｊｅｃｔ

　　       1.Construction Scale and Its Content:  20t/y sulphuric acid cartilage element, 10t/y bacteriolytic enzyme

　　       2.Market Analysis:  The biological resources for producing biochemical materials are very rich, but a great deal of it belongs to resource-relying products in a long run. Some kinds of resources can be produced by the way of gene recombination, but it can not meet the need of the market. The biochemical medicine produced in the company is to make use of the local biological resources and meet the clerical need of hospitals. It is in great need in market. Sulphuric aid cartilage element the biochemical medicinal product which is the largest exported product to the U.S. and European countries. Bacteriolytic enzyme can be used to decompose cell wall and has a wide application. The amount presently produced in the country can only meet the one third of market demand and mainly sold to Dalian and Shanghai. 

　　       3.Construction Condition: The project has been listed in the State-supporting items and approved to enter Lishi Light Industry Sci-tech Park with a good facilities and infrastructure. Sulphuric acid cartilage element is an acid carbonhydrate medicine extracted from cartilage tissues of pig, cow and sheep. Bacteriolytic enzyme is an enzyme preparation extracted for egg whites. The raw material for production can be obtained locally.

　　       4.Total Investment: The total investment will be 50 million yuan of which 10 million yuan will be self funded and 40 million yuan introduced.

　　       5.Construction period: 1 year

　　       6.Benefit Analysis: After its completion, the annual sales income will be 41.6 million yuan, profit 13.4 million yuan, and tax 4 million yuan. It can provide 200 job opportunities.

　　       7.Cooperation Form

　　       Joint Venture, Cooperation

　　ＩＩＩ．Ｃｏｎｔａｃｔ Ｆｏｒｍ

　　       Add:Lishi Development Planning Bureau

　　       Liaison:Guo Chunyuan

　　       Tele:0358-8222524